Results 241 to 250 of about 5,135,152 (380)

Gastric cancer genomics study using reference human pangenomes. [PDF]

Life Sci Alliance
Jiao D, Dong X, Fan S, Liu X, Yu Y, Wei C.   +5 more
europepmc   +1 more source

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.

Cell, 2018
L. Ding, Matthew H. Bailey, E. Porta-Pardo, V. Thorsson, A. Colaprico, D. Bertrand, David L. Gibbs, A. Weerasinghe, Kuan-lin Huang, Collin J Tokheim, I. Cortés-Ciriano, R. Jayasinghe, Feng Chen, Lihua Yu, Sam Q. Sun, Catharina Olsen, Jaegil Kim, Alison M. Taylor, A. Cherniack, Rehan Akbani, Chayaporn Suphavilai, N. Nagarajan, Joshua M. Stuart, G. Mills, Matthew A. Wyczalkowski, B. Vincent, C. Hutter, J. Zenklusen, K. Hoadley, M. Wendl, L. Shmulevich, A. Lazar, D. Wheeler, G. Getz   +33 more
semanticscholar   +1 more source

Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon‐19‐deleted advanced NSCLC mutation

FEBS Open Bio, EarlyView.
Osimertinib reduces angiogenesis and PDL1 expression in in ovo tumors, transforming them into ‘cold tumors’ with lower immune activity. Anatomopathological and transcriptomic analyses highlight its therapeutic impact on tumor biology. This study underscores osimertinib's potential to reshape the tumor microenvironment and provides insights into its ...
David Barthélémy, Arnaud Vigneron, Xavier Rousset, Jérome Guitton, Emmanuel Grolleau, Margaux Raffin, Julie Balandier, Gaëlle Lescuyer, Mathilde Bardou, Florence Geiguer, Sébastien Couraud, Claire Bardel, Jean Viallet, Nazim Benzerdjeb, Léa Payen   +14 more
wiley   +1 more source

FuSViz-visualization and interpretation of structural variation using cancer genomics and transcriptomics data. [PDF]

Nucleic Acids Res
Zhao S, Nakken S, Vodak D, Hovig E.
europepmc   +1 more source

Editorial: Sex Difference in Cancer Genomics and Its Impact on Therapy. [PDF]

Front Genet, 2021
Peng S, Waite K, Rubin JB, Barnholtz-Sloan JS.   +3 more
europepmc   +1 more source

An entity tagger for recognizing acquired genomic variations in cancer literature [PDF]

, 2004
Ryan McDonald, R. Scott Winters, Mark A. Mandel, Yang Jin, Peter S. White, Fernando Pereira   +5 more
openalex   +1 more source

Beyond digital twins: the role of foundation models in enhancing the interpretability of multiomics modalities in precision medicine

FEBS Open Bio, EarlyView.
This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi, Xin Gao, Takashi Gojobori   +2 more
wiley   +1 more source

Editorial: Cutaneous oncology and skin cancer genomics. [PDF]

Front Med (Lausanne)
Dasgeb B.
europepmc   +1 more source

"Doing Good" in U.S. Cancer Genomics? Valuation practices across the boundaries of research and care in rural community oncology. [PDF]

New Genet Soc, 2022
Darling KW, Kohut M, Leeds S, Anderson EC, Han PKJ.   +4 more
europepmc   +1 more source

Commentary: Study of the Neurobehavioral Consequences of Childhood Cancer: Entering the Genomic Era? [PDF]

, 2004
Pim Brouwers
openalex   +1 more source